Mol. Cells 2010; 30(4): 341-345
Published online September 10, 2010
https://doi.org/10.1007/s10059-010-0124-x
© The Korean Society for Molecular and Cellular Biology
Correspondence to : *Correspondence: bjlee@ulsan.ac.kr
Obesity, a condition characterized by increased fat con-tent and altered secretion of adipokines, is a risk factor for postmenopausal breast cancer. Visfatin has recently been established as a novel adipokine that is highly enriched in visceral fat. Here we report that visfatin regulated proliferation of MCF-7 human breast cancer cells. Exogenous administration of recombinant visfatin increased cell proliferation and DNA synthesis rate in MCF-7 cells. Furthermore, visfatin activated G1-S phase cell cycle progression by upregulation of cyclin D1 and cdk2 expression. Visfatin also increased the expression of matrix metalloproteinases 2, matrix metalloproteinases 9, and vascular endothelial growth factor genes, suggesting that it may function in metastasis and angiogenesis of breast cancer. Taken together, these findings suggest that visfatin plays an important role in breast cancer progression.
Keywords angiogenesis, breast cancer, metastasis, proliferation, visfatin
Mol. Cells 2010; 30(4): 341-345
Published online October 31, 2010 https://doi.org/10.1007/s10059-010-0124-x
Copyright © The Korean Society for Molecular and Cellular Biology.
Jae Geun Kim1,2, Eun Ok Kim1, Bo Ra Jeong1, Young Joo Min2,4, Jeong Woo Park1,2, Eun Sook Kim3, Il Seong Namgoong3, Young Il Kim3, and Byung Ju Lee1,*
1Department of Biological Sciences, College of Natural Sciences, University of Ulsan, Ulsan 680-749, Korea, 2Biomedical Research Center, College of Medicine, University of Ulsan, Ulsan 682-714, Korea, 3Department of Internal Medicine, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan 682-714, Korea, 4Division of Hematology and Oncology, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan 682-714, Korea
Correspondence to:*Correspondence: bjlee@ulsan.ac.kr
Obesity, a condition characterized by increased fat con-tent and altered secretion of adipokines, is a risk factor for postmenopausal breast cancer. Visfatin has recently been established as a novel adipokine that is highly enriched in visceral fat. Here we report that visfatin regulated proliferation of MCF-7 human breast cancer cells. Exogenous administration of recombinant visfatin increased cell proliferation and DNA synthesis rate in MCF-7 cells. Furthermore, visfatin activated G1-S phase cell cycle progression by upregulation of cyclin D1 and cdk2 expression. Visfatin also increased the expression of matrix metalloproteinases 2, matrix metalloproteinases 9, and vascular endothelial growth factor genes, suggesting that it may function in metastasis and angiogenesis of breast cancer. Taken together, these findings suggest that visfatin plays an important role in breast cancer progression.
Keywords: angiogenesis, breast cancer, metastasis, proliferation, visfatin
Min Ji Park, Eunji Jeong, Eun Ji Lee, Hyeon Ji Choi, Bo Hyun Moon, Keunsoo Kang, and Suhwan Chang
Mol. Cells -0001; (): https://doi.org/10.14348/molcells.2023.2174Cho-Won Kim, Hong Kyu Lee, Min-Woo Nam, Youngdong Choi, and Kyung-Chul Choi
Mol. Cells 2022; 45(12): 935-949 https://doi.org/10.14348/molcells.2022.0105Min Soo Kim, Won Sung Lee, and Wook Jin
Mol. Cells 2016; 39(3): 258-265 https://doi.org/10.14348/molcells.2016.2310